Sumitomo Mitsui Trust Holdings Inc. increased its stake in shares of CVS Health Corp (NYSE:CVS) by 2.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,334,640 shares of the pharmacy operator’s stock after buying an additional 76,995 shares during the period. Sumitomo Mitsui Trust Holdings Inc.’s holdings in CVS Health were worth $262,503,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in CVS. Trust Co. of Toledo NA OH raised its position in shares of CVS Health by 3.5% in the third quarter. Trust Co. of Toledo NA OH now owns 19,653 shares of the pharmacy operator’s stock valued at $1,548,000 after buying an additional 661 shares during the last quarter. Kiley Juergens Wealth Management LLC raised its position in shares of CVS Health by 41.5% in the third quarter. Kiley Juergens Wealth Management LLC now owns 2,270 shares of the pharmacy operator’s stock valued at $178,000 after buying an additional 666 shares during the last quarter. Westchester Capital Management Inc. raised its position in shares of CVS Health by 0.7% in the third quarter. Westchester Capital Management Inc. now owns 104,444 shares of the pharmacy operator’s stock valued at $8,222,000 after buying an additional 695 shares during the last quarter. Wellington Shields & Co. LLC raised its position in shares of CVS Health by 12.3% in the third quarter. Wellington Shields & Co. LLC now owns 6,400 shares of the pharmacy operator’s stock valued at $504,000 after buying an additional 700 shares during the last quarter. Finally, Northwest Investment Counselors LLC raised its position in shares of CVS Health by 2.5% in the third quarter. Northwest Investment Counselors LLC now owns 29,103 shares of the pharmacy operator’s stock valued at $2,291,000 after buying an additional 704 shares during the last quarter. 83.03% of the stock is currently owned by hedge funds and other institutional investors.

Shares of CVS stock opened at $75.52 on Wednesday. CVS Health Corp has a one year low of $60.14 and a one year high of $83.88. The company has a quick ratio of 1.94, a current ratio of 2.44 and a debt-to-equity ratio of 1.66. The company has a market cap of $80.03 billion, a P/E ratio of 12.80, a P/E/G ratio of 1.05 and a beta of 0.98.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Tuesday, November 6th. The pharmacy operator reported $1.73 EPS for the quarter, topping the consensus estimate of $1.71 by $0.02. CVS Health had a net margin of 1.65% and a return on equity of 18.69%. The firm had revenue of $47.27 billion during the quarter, compared to analyst estimates of $47.22 billion. During the same quarter in the prior year, the business posted $1.50 earnings per share. CVS Health’s revenue for the quarter was up 2.4% compared to the same quarter last year. Research analysts anticipate that CVS Health Corp will post 7.02 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 1st. Shareholders of record on Wednesday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date was Tuesday, October 23rd. This represents a $2.00 annualized dividend and a yield of 2.65%. CVS Health’s dividend payout ratio is currently 33.90%.

In other CVS Health news, EVP Lisa Bisaccia sold 21,534 shares of the business’s stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $80.00, for a total transaction of $1,722,720.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Kevin Hourican sold 8,564 shares of the business’s stock in a transaction that occurred on Monday, August 27th. The stock was sold at an average price of $75.00, for a total transaction of $642,300.00. Following the sale, the executive vice president now owns 12,135 shares of the company’s stock, valued at $910,125. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 57,638 shares of company stock valued at $4,558,875. 0.53% of the stock is owned by insiders.

A number of equities analysts have recently weighed in on the stock. ValuEngine raised shares of CVS Health from a “sell” rating to a “hold” rating in a research report on Tuesday, November 6th. Loop Capital set a $80.00 price target on shares of CVS Health and gave the stock a “hold” rating in a research report on Friday, November 9th. Royal Bank of Canada set a $100.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, November 7th. Morgan Stanley set a $100.00 price target on shares of CVS Health and gave the stock a “buy” rating in a research report on Wednesday, November 7th. Finally, Argus upped their price target on shares of CVS Health to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, November 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, eleven have issued a buy rating and two have given a strong buy rating to the company. The stock has an average rating of “Buy” and an average price target of $90.04.

TRADEMARK VIOLATION NOTICE: This article was reported by Daily Political and is the sole property of of Daily Political. If you are viewing this article on another website, it was copied illegally and reposted in violation of US & international copyright & trademark law. The correct version of this article can be viewed at https://www.dailypolitical.com/2018/11/21/cvs-health-corp-cvs-shares-bought-by-sumitomo-mitsui-trust-holdings-inc.html.

About CVS Health

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Read More: The Role of a Fiduciary and Individual Investors

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.